Lia D'Ambrosio
- Complex Pleuropulmonary InfectionsEdited by Gernot Rohde and Dragan SuboticBook | Published in 2013DOI: 10.1183/1025448x.erm6113ISBN (electronic): 978-1-84984-037-8
- TB and MDR-TB: what is new in 2012?By Marina Tadolini, Rosella Centis, Lia D'Ambrosio and Giovanni Battista MiglioriMarina Tadolini1World Health Organization Consultant, Global Fund Technical Review Panel memberRosella Centis2World Health Organization Collaborating Centre for Tuberculosis and Lung Disease, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'Ambrosio2World Health Organization Collaborating Centre for Tuberculosis and Lung Disease, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyGiovanni Battista Migliori2World Health Organization Collaborating Centre for Tuberculosis and Lung Disease, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolonesBy Giovanni Battista Migliori, Miranda W. Langendam, Lia D'Ambrosio, Rosella Centis, Francesco Blasi, Emma Huitric, Davide Manissero and Marieke J. van der WerfGiovanni Battista Migliori*WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate##These authors contributed equallyMiranda W. Langendam#Dutch Cochrane Centre, Academic Medical Center, University of Amsterdam##These authors contributed equallyLia D'Ambrosio*WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateRosella Centis*WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateFrancesco Blasi¶Respiratory Medicine Section, Dipartimento Toraco-Polmonare e Cardiocircolatorio, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyEmma Huitric+European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenDavide Manissero+European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenMarieke J. van der Werf§Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, AmsterdamfKNCV Tuberculosis Foundation, The Hague, The Netherlands
- Availability of anti-tuberculosis drugs in EuropeBy Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Graham Bothamley, Daniela M. Cirillo, Saverio De Lorenzo, Gunar Guenther, Kai Kliiman, Ralf Muetterlein, Victor Spinu, Miguel Villar, Jean-Pierre Zellweger, Andreas Sandgren, Emma Huitric, Christoph Lange, Davide Manissero and Giovanni Battista MiglioriGiovanni Sotgiu*Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, SassariLia D'Ambrosio#WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateRosella Centis#WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateGraham Bothamley¶Homerton University Hospital, London, UKDaniela M. Cirillo+Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, MilanSaverio De Lorenzo§E. Morelli Hospital, Reference Hospital for MDR and HIV TB, Sondalo, ItalyGunar GuentherfDivision of Clinical Infectious Diseases, Medical Clinic, Research Center Borstel, BorstelKai Kliiman**Dept of Pulmonary Medicine, University of Tartu, Tartu, EstoniaRalf Muetterlein##Dept of Medicine, Parsberg Hospital, Parsberg, GermanyVictor Spinu¶¶MDR-TB Centre, Marius Nasta Institute of Pulmonology, Bucharest, RomaniaMiguel Villar++General Directorate of Health in Lisbon and Lung Diseases Centre of Venda Nova, Amadora, PortugalJean-Pierre Zellweger§§Swiss Lung Association, Berne, SwitzerlandAndreas SandgrenffSurveillance and Response Support Unit, European Centre for Disease Prevention and ControlEmma Huitric***Office of the Chief Scientist, European Centre for Disease Prevention and Control, Tomtebodavägen, Stockholm, SwedenChristoph LangefDivision of Clinical Infectious Diseases, Medical Clinic, Research Center Borstel, BorstelDavide Manissero***Office of the Chief Scientist, European Centre for Disease Prevention and Control, Tomtebodavägen, Stockholm, SwedenGiovanni Battista Migliori#WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate
- Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysisBy Giovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, Jan-William C. Alffenaar, Holly A. Anger, Jose A. Caminero, Paolo Castiglia, Saverio De Lorenzo, Giovanni Ferrara, Won-Jung Koh, Giesela F. Schecter, Tae S. Shim, Rupak Singla, Alena Skrahina, Antonio Spanevello, Zarir F. Udwadia, Miquel Villar, Elisabetta Zampogna, Jean-Pierre Zellweger, Alimuddin Zumla and Giovanni Battista MiglioriGiovanni SotgiuFor a full list of affiliations details please see the Acknowledgements sectionRosella CentisFor a full list of affiliations details please see the Acknowledgements sectionLia D'AmbrosioFor a full list of affiliations details please see the Acknowledgements sectionJan-William C. AlffenaarFor a full list of affiliations details please see the Acknowledgements sectionHolly A. AngerFor a full list of affiliations details please see the Acknowledgements sectionJose A. CamineroFor a full list of affiliations details please see the Acknowledgements sectionPaolo CastigliaFor a full list of affiliations details please see the Acknowledgements sectionSaverio De LorenzoFor a full list of affiliations details please see the Acknowledgements sectionGiovanni FerraraFor a full list of affiliations details please see the Acknowledgements sectionWon-Jung KohFor a full list of affiliations details please see the Acknowledgements sectionGiesela F. SchecterFor a full list of affiliations details please see the Acknowledgements sectionTae S. ShimFor a full list of affiliations details please see the Acknowledgements sectionRupak SinglaFor a full list of affiliations details please see the Acknowledgements sectionAlena SkrahinaFor a full list of affiliations details please see the Acknowledgements sectionAntonio SpanevelloFor a full list of affiliations details please see the Acknowledgements sectionZarir F. UdwadiaFor a full list of affiliations details please see the Acknowledgements sectionMiquel VillarFor a full list of affiliations details please see the Acknowledgements sectionElisabetta ZampognaFor a full list of affiliations details please see the Acknowledgements sectionJean-Pierre ZellwegerFor a full list of affiliations details please see the Acknowledgements sectionAlimuddin ZumlaFor a full list of affiliations details please see the Acknowledgements sectionGiovanni Battista MiglioriFor a full list of affiliations details please see the Acknowledgements section
- Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TBBy Saverio De Lorenzo, Jan Wilem Alffenaar, Giovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, Simon Tiberi, Mathieu S. Bolhuis, Richard van Altena, Piero Viggiani, Andrea Piana, Antonio Spanevello and Giovanni Battista MiglioriSaverio De Lorenzo*AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo**Both authors contributed equallyJan Wilem Alffenaar#Dept of Hospital and Clinical Pharmacy, University of Groningen, University Medical Center Groningen, Groningen**Both authors contributed equallyGiovanni Sotgiu¶Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, SassariRosella Centis+World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateLia D'Ambrosio+World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateSimon Tiberi*AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, SondaloMathieu S. Bolhuis#Dept of Hospital and Clinical Pharmacy, University of Groningen, University Medical Center Groningen, GroningenRichard van Altena§Tuberculosis Center Beatrixoord, University of Groningen, University Medical Center Groningen, Haren, The NetherlandsPiero Viggiani*AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, SondaloAndrea Piana¶Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, SassariAntonio Spanevello*AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, SondalofUniversità degli Studi dell'Insubria, Varese, ItalyGiovanni Battista Migliori+World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate
- Old ideas to innovate tuberculosis control: preventive treatment to achieve eliminationBy Roland Diel, Robert Loddenkemper, Jean-Pierre Zellweger, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Marieke J. van der Werf, Masoud Dara, Anne Detjen, Peter Gondrie, Lee Reichman, Francesco Blasi and Giovanni Battista MiglioriRoland Diel1Institute for Epidemiology, University Medical Hospital Schleswig-Holstein, Member of the German Center for Lung Research (DZL), KielRobert Loddenkemper2German Central Committee Against Tuberculosis, Berlin, GermanyJean-Pierre Zellweger3Swiss Lung Association, Bern, SwitzerlandGiovanni Sotgiu4Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, SassariLia D'Ambrosio5World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateRosella Centis5World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateMarieke J. van der Werf6European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenMasoud Dara7World Health Organization, Regional Office for Europe, Copenhagen, DenmarkAnne Detjen8International Union Against Tuberculosis and Lung Disease, New York, NY,Peter Gondrie9International Unit, KNCV Tuberculosis Foundation, The Hague, The NetherlandsLee Reichman10Global Tuberculosis Institute, New Jersey Medical School, Newark, NJ, USAFrancesco Blasi11Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori5World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate
- Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomesBy Dennis Falzon, Neel Gandhi, Giovanni B. Migliori, Giovanni Sotgiu, Helen S. Cox, Timothy H. Holtz, Maria-Graciela Hollm-Delgado, Salmaan Keshavjee, Kathryn DeRiemer, Rosella Centis, Lia D'Ambrosio, Christoph G. Lange, Melissa Bauer and Dick MenziesDennis Falzon1Stop TB Dept, World Health Organization, Geneva, SwitzerlandNeel Gandhi2Divisions of General Internal Medicine, Infectious Diseases and Epidemiology, Albert Einstein College of Medicine, New York, NYGiovanni B. Migliori3World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateGiovanni Sotgiu4Dept of Biomedical Sciences, University of Sassari, Sassari, ItalyHelen S. Cox5Médecins Sans Frontières, Cape Town, South AfricaTimothy H. Holtz6US Centers for Disease Control and Prevention, HIV/STD Research Program, Bangkok, ThailandMaria-Graciela Hollm-Delgado7Montreal Chest Institute, McGill University, Montreal, QC, CanadaSalmaan Keshavjee8Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MAKathryn DeRiemer9School of Medicine, University of California Davis, Davis, CA, USARosella Centis3World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateLia D'Ambrosio3World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateChristoph G. Lange10Clinical Infectious Diseases, Tuberculosis Center Borstel, Borstel, GermanyMelissa Bauer7Montreal Chest Institute, McGill University, Montreal, QC, Canada11Dept of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QCDick Menzies7Montreal Chest Institute, McGill University, Montreal, QC, Canada
- Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysisBy Giovanni Battista Migliori, Giovanni Sotgiu, Neel R. Gandhi, Dennis Falzon, Kathryn DeRiemer, Rosella Centis, Maria-Graciela Hollm-Delgado, Domingo Palmero, Carlos Pérez-Guzmán, Mario H. Vargas, Lia D'Ambrosio, Antonio Spanevello, Melissa Bauer, Edward D. Chan, H. Simon Schaaf, Salmaan Keshavjee, Timothy H. Holtz, Dick Menzies and The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TBGiovanni Battista Migliori1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate15Both authors contributed equallyGiovanni Sotgiu2Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Sassari15Both authors contributed equallyNeel R. Gandhi3Dept of Medicine and Dept of Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY3Dept of Medicine and Dept of Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NYDennis Falzon4Stop TB Dept, World Health Organization, Geneva, SwitzerlandKathryn DeRiemer5School of Medicine, University of California Davis, Davis, CARosella Centis1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateMaria-Graciela Hollm-Delgado6Montreal Chest Institute, McGill University, Montreal, QC, CanadaDomingo Palmero7Pulmonology Division, Hospital F. J. Muñiz, Buenos Aires, ArgentinaCarlos Pérez-Guzmán8Instituto de Servicios de Salud del Estado de Aguascalientes, Unidad de Medicina Ambulatoria Aguascalientes, Instituto Mexicano del Seguro Social, AguascalientesMario H. Vargas9Instituto Nacional de Enfermedades Respiratorias, and Medical Research Unit in Respiratory Diseases, Instituto Mexicano del Seguro Social, Mexico City, MexicoLia D'Ambrosio1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateAntonio Spanevello10Università degli Studi dell’ Insubria, Varese and Division of Pneumology, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyMelissa Bauer6Montreal Chest Institute, McGill University, Montreal, QC, CanadaEdward D. Chan11Pulmonary Dept, Denver Veterans Affair Medical Center and National Jewish Health, Denver, COH. Simon Schaaf12Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South AfricaSalmaan Keshavjee13Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MATimothy H. Holtz14Centers for Disease Control and Prevention, Atlanta, GA, USADick Menzies6Montreal Chest Institute, McGill University, Montreal, QC, Canada16A full list of the Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB members can be found in the Acknowledgements section
- A case of resistance beyond extensively drug-resistant tuberculosis in JapanBy Giovanni Battista Migliori, Rosella Centis and Lia D'AmbrosioGiovanni Battista MiglioriWorld Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyRosella CentisWorld Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'AmbrosioWorld Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIFBy Karin Weyer, Fuad Mirzayev, Giovanni Battista Migliori, Wayne Van Gemert, Lia D'Ambrosio, Matteo Zignol, Katherine Floyd, Rosella Centis, Daniela M. Cirillo, Enrico Tortoli, Chris Gilpin, Jean de Dieu Iragena, Dennis Falzon and Mario RaviglioneKarin Weyer1Stop TB Dept, World Health Organization, Geneva, SwitzerlandFuad Mirzayev1Stop TB Dept, World Health Organization, Geneva, SwitzerlandGiovanni Battista Migliori2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateWayne Van Gemert1Stop TB Dept, World Health Organization, Geneva, SwitzerlandLia D'Ambrosio2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateMatteo Zignol1Stop TB Dept, World Health Organization, Geneva, SwitzerlandKatherine Floyd1Stop TB Dept, World Health Organization, Geneva, SwitzerlandRosella Centis2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateDaniela M. Cirillo3Emerging Pathogens Unit TB Supranational Reference Laboratory, San Raffaele Scientific Institute, Milan, ItalyEnrico Tortoli3Emerging Pathogens Unit TB Supranational Reference Laboratory, San Raffaele Scientific Institute, Milan, ItalyChris Gilpin1Stop TB Dept, World Health Organization, Geneva, SwitzerlandJean de Dieu Iragena1Stop TB Dept, World Health Organization, Geneva, SwitzerlandDennis Falzon1Stop TB Dept, World Health Organization, Geneva, SwitzerlandMario Raviglione1Stop TB Dept, World Health Organization, Geneva, Switzerland
- Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidenceBy Giovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, Antonio Spanevello and Giovanni Battista MiglioriGiovanni Sotgiu1Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, SassariRosella Centis2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateLia D'Ambrosio2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateAntonio Spanevello3Università degli Studi dell'Insubria, Varese, and Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyGiovanni Battista Migliori2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate
- Temporal trend analysis of TB treatment outcomes in the WHO European regionBy Masoud Dara, Giovanni Sotgiu, Andrei Dadu, Hans Kluge, Malgorzata Grzemska, Rosella Centis, Lia D'Ambrosio and Giovanni Battista MiglioriMasoud Dara1Regional Office for Europe, World Health Organization, Copenhagen, DenmarkGiovanni Sotgiu3Epidemiology and Biostatistics Unit, Department of Biomedical Sciences, University of Sassari, Sassari, ItalyAndrei Dadu1Regional Office for Europe, World Health Organization, Copenhagen, DenmarkHans Kluge1Regional Office for Europe, World Health Organization, Copenhagen, DenmarkMalgorzata Grzemska4Stop TB Department, World Health Organization, Geneva, SwitzerlandRosella Centis2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'Ambrosio2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyGiovanni Battista Migliori2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Tuberculosis elimination: theory and practice in EuropeBy Lia D'Ambrosio, Masoud Dara, Marina Tadolini, Rosella Centis, Giovanni Sotgiu, Marieke J. van der Werf, Mina Gaga, Daniela Cirillo, Antonio Spanevello, Mario Raviglione, Francesco Blasi and Giovanni Battista MiglioriLia D'Ambrosio1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate11L. D’Ambrosio and M. Dara contributed equally to the studyMasoud Dara2World Health Organization, Regional Office for Europe, Copenhagen, Denmark11L. D’Ambrosio and M. Dara contributed equally to the studyMarina Tadolini3Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, BolognaRosella Centis1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, TradateGiovanni Sotgiu4Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU SassariMarieke J. van der Werf5European Centre for Disease Prevention and Control, Stockholm, SwedenMina Gaga67th Respiratory Medicine Dept, Athens Chest Hospital, Athens, GreeceDaniela Cirillo7Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, MilanAntonio Spanevello1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate8Università degli Studi dell'Insubria, VareseMario Raviglione9Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi10Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate
- The European Union standards for tuberculosis care: do they need an update?By Marieke J. van der Werf, Andreas Sandgren, Lia D'Ambrosio, Francesco Blasi and Giovanni Battista MiglioriMarieke J. van der Werf1European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenAndreas Sandgren1European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenLia D'Ambrosio2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateFrancesco Blasi3Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate
- Poor treatment outcomes of XDR-TB patients in resource-limited settingsBy Giovanni Sotgiu, Elize Pietersen, Rosella Centis, Malika Davids, Andrea Piana, Devan Vaghela, Kai Kliiman, Lia D'Ambrosio, Grant Theron, Giovanni Battista Migliori and Keertan DhedaGiovanni Sotgiu1Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, ItalyElize Pietersen2Lung Infection and Immunity Unit, Division of Pulmonology & UCT Lung Institute, Department of Medicine, University of Cape Town, South AfricaRosella Centis3World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyMalika Davids2Lung Infection and Immunity Unit, Division of Pulmonology & UCT Lung Institute, Department of Medicine, University of Cape Town, South AfricaAndrea Piana1Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, ItalyDevan Vaghela2Lung Infection and Immunity Unit, Division of Pulmonology & UCT Lung Institute, Department of Medicine, University of Cape Town, South AfricaKai Kliiman4Department of Pulmonary Medicine, University of Tartu, EstoniaLia D'Ambrosio3World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyGrant Theron2Lung Infection and Immunity Unit, Division of Pulmonology & UCT Lung Institute, Department of Medicine, University of Cape Town, South AfricaGiovanni Battista Migliori3World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyKeertan Dheda2Lung Infection and Immunity Unit, Division of Pulmonology & UCT Lung Institute, Department of Medicine, University of Cape Town, South Africa
- Rational use of tuberculosis drugs to prevent the development of drug resistanceBy Emma Huitric, Marieke J. van der Werf, Miranda W. Langendam, Lia D'Ambrosio, Rosella Centis, Francesco Blasi, G.B. Migliori and Davide ManisseroEmma Huitric1Office of the Chief Scientist, European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenMarieke J. van der Werf2Unit Knowledge Management, Research, and Policy Development, KNCV Tuberculosis Foundation, The Hague, NetherlandsMiranda W. Langendam3Dutch Cochrane Centre, Academic Medical Center, University of Amsterdam, NetherlandsLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyFrancesco Blasi5Respiratory Medicine Section, Dipartimento Toraco-Polmonare e Cardiocircolatorio, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyG.B. Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyDavide Manissero1Office of the Chief Scientist, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- Results of a tuberculin skin test survey performed in a national representative sample of young Albanian studentsBy Hasan Hafizi, Edlira Sharra, Albana Fico, Rosella Centis, Giovanni Battista Migliori, Lia D'Ambrosio, Paolo Castiglia and Giovanni SotgiuHasan Hafizi1University Lung Diseases Hospital, "Shefqet Ndroqi", Tirana, AlbaniaEdlira Sharra2National Institute of Public Health, Tirana, AlbaniaAlbana Fico3Centre for Respiratory Health & TB, Tirana, AlbaniaRosella Centis4World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyGiovanni Battista Migliori4World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'Ambrosio4World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyPaolo Castiglia5Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, ItalyGiovanni Sotgiu5Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Italy
- Impact and management of TB childhood outbreaks in EU/EEABy Giovanni Battista Migliori, Rosella Centis, Lia D'Ambrosio, Giovanni Sotgiu, Bernadette Bourdin Trunz, Richard Godfrey, Marina Tadolini, Giorgio Besozzi, Andreas Sandgren and Marieke J. van der WerfGiovanni Battista Migliori1WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyRosella Centis1WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'Ambrosio1WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyGiovanni Sotgiu2Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Sassari, ItalyBernadette Bourdin Trunz3Public Health Consultant, Tuberculosis Area, Geneva, SwitzerlandRichard Godfrey4Senior TB and HIV Consultant, Dashwood, United KingdomMarina Tadolini5Global Fund Technical Review Panel Member, World Health Organization Consultant, ItalyGiorgio Besozzi6AIPO Ricerche, Milan, ItalyAndreas Sandgren7TB Programme, European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenMarieke J. van der Werf7TB Programme, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- Protecting the TB drug pipeline. Stating the case for the rational use of FluoroquinolonesBy GB Migliori, Miranda W. Langendam, Lia D'Ambrosio, Rosella Centis, Francesco Blasi, Emma Huitric, Davide Manissero and Marieke J. van der WerfArticle | Published in 2012 in European Respiratory JournalGB MiglioriMiranda W. LangendamLia D'AmbrosioRosella CentisFrancesco BlasiEmma HuitricDavide ManisseroMarieke J. van der Werf
- Protecting the TB drug pipeline. Stating the case for the rational use of FluoroquinolonesBy GB Migliori, Miranda W. Langendam, Lia D'Ambrosio, Rosella Centis, Francesco Blasi, Emma Huitric, Davide Manissero and Marieke J. van der WerfArticle | Published in 2012 in European Respiratory JournalGB MiglioriMiranda W. LangendamLia D'AmbrosioRosella CentisFrancesco BlasiEmma HuitricDavide ManisseroMarieke J. van der Werf
- Efficacy and safety of meropenem/clavunate added to linezolid containing regimens in the treatment of M/XDR-TBBy Saverio De Lorenzo, Jan Wilem Alffenaar, Giovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, Simon Tiberi, Mathieu S Bolhuis, Richard van Altena, Piero Viggiani, Andrea Piana, Antonio Spanevello and Giovanni Battista MiglioriArticle | Published in 2012 in European Respiratory JournalSaverio De Lorenzo*AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, Italy**Equally contributedJan Wilem Alffenaar#University of Groningen, University Medical Center Groningen, Dept of Hospital and Clinical Pharmacy, Groningen, the Netherlands;**Equally contributedGiovanni Sotgiu¶Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Sassari, ItalyRosella Centis+World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'Ambrosio+World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalySimon Tiberi*AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyMathieu S Bolhuis#University of Groningen, University Medical Center Groningen, Dept of Hospital and Clinical Pharmacy, Groningen, the Netherlands;Richard van AltenafUniversity of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, the NetherlandsPiero Viggiani*AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyAndrea Piana¶Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Sassari, ItalyAntonio Spanevello§Università degli Studi dell'Insubria, Varese, and Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyGiovanni Battista Migliori+World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Tuberculosis elimination: theory and practice in EuropeBy Lia D'Ambrosio, Masoud Dara, Marina Tadolini, Rosella Centis, Giovanni Sotgiu, Marieke J. van der Werf, Mina Gaga, Daniela Cirillo, Antonio Spanevello, Mario Raviglione, Francesco Blasi and Giovanni Battista MiglioriArticle | Published in 2014 in European Respiratory JournalLia D'Ambrosio1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,11L. D’Ambrosio and M. Dara contributed equally to the study,Masoud Dara2World Health Organization, Regional Office for Europe, Copenhagen, Denmark11L. D’Ambrosio and M. Dara contributed equally to the study,Marina Tadolini3Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna,Rosella Centis1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,Giovanni Sotgiu4Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari,Marieke J. van der Werf5European Centre for Disease Prevention and Control, Stockholm, SwedenMina Gaga67th Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece,Daniela Cirillo7Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milan,Antonio Spanevello1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,8Università degli Studi dell'Insubria, Varese,Mario Raviglione9Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi10Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,
- Old ideas to innovate TB control: preventive treatment to achieve eliminationBy Roland Diel, Robert Loddenkemper, Jean-Pierre Zellweger, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Marieke J. van der Werf, Masoud Dara, Anne Detjen, Peter Gondrie, Lee Reichman, Francesco Blasi and Giovanni Battista MiglioriArticle | Published in 2013 in European Respiratory JournalRoland Diel*Institute for Epidemiology, Medical Center, Christian-Albrechts-University Kiel, GermanyRobert Loddenkemper#German Central Committee Against Tuberculosis, Berlin, GermanyJean-Pierre Zellweger¶Swiss Lung Association, Bern, SwitzerlandGiovanni Sotgiu+Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Sassari, ItalyLia D'Ambrosio§World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyRosella Centis§World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyMarieke J. van der WerffEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenMasoud Dara**World Health Organization, Regional Office for Europe, Copenhagen, DenmarkAnne Detjen##International Union Against Tuberculosis and Lung Disease, New York, USAPeter Gondrie¶¶International Unit, KNCV Tuberculosis Foundation, The Hague, The NetherlandsLee Reichman++Global Tuberculosis Institute, New Jersey Medical School, Newark, NJ, USAFrancesco Blasi§§Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori§World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Tuberculosis elimination: theory and practice in EuropeBy Lia D'Ambrosio, Masoud Dara, Marina Tadolini, Rosella Centis, Giovanni Sotgiu, Marieke J. van der Werf, Mina Gaga, Daniela Cirillo, Antonio Spanevello, Mario Raviglione, Francesco Blasi and Giovanni Battista MiglioriArticle | Published in 2014 in European Respiratory JournalLia D'Ambrosio1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,11L. D’Ambrosio and M. Dara contributed equally to the study,Masoud Dara2World Health Organization, Regional Office for Europe, Copenhagen, Denmark11L. D’Ambrosio and M. Dara contributed equally to the study,Marina Tadolini3Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna,Rosella Centis1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,Giovanni Sotgiu4Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari,Marieke J. van der Werf5European Centre for Disease Prevention and Control, Stockholm, SwedenMina Gaga67th Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece,Daniela Cirillo7Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milan,Antonio Spanevello1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,8Università degli Studi dell'Insubria, Varese,Mario Raviglione9Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi10Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,
- Bedaquiline in MDR-/XDR-TB cases: first experience on campassionate useBy Simon Tiberi, Saverio De Lorenzo, Rosella Centis, Pietro Viggiani, Lia D'Ambrosio and Giovanni Battista MiglioriArticle | Published in 2013 in European Respiratory JournalSimon Tiberi*Imperial College Healthcare NHS Trust, London, United KingdomSaverio De Lorenzo#AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyRosella Centis¶World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyPietro Viggiani#AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyLia D'Ambrosio¶World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyGiovanni Battista Migliori¶World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- ERS/WHO TB consilium: reporting on initial 10 casesBy Lia D'Ambrosio, Marina Tadolini, Stephane Dupasquier, Simon Tiberi, Rosella Centis, Masoud Dara, Francesco Blasi and Giovanni Battista MiglioriArticle | Published in 2013 in European Respiratory JournalLia D'Ambrosio*World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy**Equally contributedMarina Tadolini#Section of Infectious Diseases, Dept of Medical and Surgical Sciences, “Alma Mater Studiorum”, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy**Equally contributedStephane Dupasquier¶IT Dept, European Respiratory Society, Lausanne, SwitzerlandSimon Tiberi+Imperial College Healthcare NHS Trust, London, United KingdomRosella Centis*World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyMasoud Dara§World Health Organization Regional Office for Europe, Copenhagen, DenmarkFrancesco BlasifDipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori*World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strainsBy Giovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, Paolo Castiglia and Giovanni Battista MiglioriGiovanni Sotgiu1Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari–Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyRosella Centis2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'Ambrosio2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyPaolo Castiglia1Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari–Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyGiovanni Battista Migliori2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- The European union standards for tuberculosis care: Do they need an update?By Marieke J. van der Werf, Andreas Sandgren, Lia D'Ambrosio, Francesco Blasi and Giovanni Battista MiglioriMarieke J. van der Werf1Tuberculosis Programme, European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenAndreas Sandgren1Tuberculosis Programme, European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenLia D'Ambrosio2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyFrancesco Blasi3Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori2WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Towards tuberculosis elimination: an action framework for low-incidence countriesBy Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Lia D'Ambrosio, Gerard de Vries, Roland Diel, Paul Douglas, Dennis Falzon, Marc-Andre Gaudreau, Delia Goletti, Edilberto R. González Ochoa, Philip LoBue, Alberto Matteelli, Howard Njoo, Ivan Solovic, Alistair Story, Tamara Tayeb, Marieke J. van der Werf, Diana Weil, Jean-Pierre Zellweger, Mohamed Abdel Aziz, Mohamed R.M. Al Lawati, Stefano Aliberti, Wouter Arrazola de Oñate, Draurio Barreira, Vineet Bhatia, Francesco Blasi, Amy Bloom, Judith Bruchfeld, Francesco Castelli, Rosella Centis, Daniel Chemtob, Daniela M. Cirillo, Alberto Colorado, Andrei Dadu, Ulf R. Dahle, Laura De Paoli, Hannah M. Dias, Raquel Duarte, Lanfranco Fattorini, Mina Gaga, Haileyesus Getahun, Philippe Glaziou, Lasha Goguadze, Mirtha del Granado, Walter Haas, Asko Järvinen, Geun-Yong Kwon, Davide Mosca, Payam Nahid, Nobuyuki Nishikiori, Isabel Noguer, Joan O'Donnell, Analita Pace-Asciak, Maria G. Pompa, Gilda G. Popescu, Carlos Robalo Cordeiro, Karin Rønning, Morten Ruhwald, Jean-Paul Sculier, Aleksandar Simunović, Alison Smith-Palmer, Giovanni Sotgiu, Giorgia Sulis, Carlos A. Torres-Duque, Kazunori Umeki, Mukund Uplekar, Catharina van Weezenbeek, Tuula Vasankari, Robert J. Vitillo, Constantia Voniatis, Maryse Wanlin and Mario C. RaviglioneKnut Lönnroth1Global TB Programme, World Health Organization, Geneva, Switzerland60Both authors contributed equallyGiovanni Battista Migliori2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy60Both authors contributed equallyIbrahim Abubakar3TB Section, University College London and Public Health England, London, UKLia D'Ambrosio2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyGerard de Vries4KNCV Tuberculosis Foundation, The Hague, The NetherlandsRoland Diel5University Hospital Schleswig Holstein, Institute for Epidemiology, Kiel, GermanyPaul Douglas6Global Health Borders Refugee and Onshore Services, Dept of Immigration and Border Protection, Sydney, AustraliaDennis Falzon1Global TB Programme, World Health Organization, Geneva, SwitzerlandMarc-Andre Gaudreau7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaDelia Goletti8National Institute for Infectious Diseases, Rome, ItalyEdilberto R. González Ochoa9Research and Surveillance Group on TB, Leprosy and ARI, Epidemiology Board, Institute of Tropical Medicine “Pedro Kourí”, Havana, CubaPhilip LoBue10Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USAAlberto Matteelli1Global TB Programme, World Health Organization, Geneva, SwitzerlandHoward Njoo7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaIvan Solovic11TB Dept, National Institute for TB, Respiratory Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ružomberok, SlovakiaAlistair Story12Find and Treat, London, UKTamara Tayeb13National TB Control Programme, Ministry of Health, Riyadh, Saudi ArabiaMarieke J. van der Werf14European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenDiana Weil1Global TB Programme, World Health Organization, Geneva, SwitzerlandJean-Pierre Zellweger15Swiss Lung Association, Bern, SwitzerlandMohamed Abdel Aziz16WHO Regional Office for the Eastern Mediterranean, Cairo, EgyptMohamed R.M. Al Lawati17Ministry of Health, Muscat, OmanStefano Aliberti18Università degli Studi di Milano – Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyWouter Arrazola de Oñate19Belgian Lung and Tuberculosis Association, Brussels, BelgiumDraurio Barreira20Ministry of Health, Brasilia, BrazilVineet Bhatia1Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi21Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyAmy Bloom22US Agency for International Development, Washington, DC, USAJudith Bruchfeld23Unit of Infectious Diseases, Institution of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenFrancesco Castelli24University of Brescia, Brescia, ItalyRosella Centis2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyDaniel Chemtob25Ministry of Health, Jerusalem, IsraelDaniela M. Cirillo26IRCCS San Raffaele Scientific Institute, Milan, ItalyAlberto Colorado27Advocates for Health International, San Diego, CA, USAAndrei Dadu28TB and M/XDR-TB Control Programme, WHO Regional Office for Europe, Copenhagen, DenmarkUlf R. Dahle29Norwegian Institute of Public Health, Oslo, NorwayLaura De Paoli30Médecins sans Frontières, Rome, ItalyHannah M. Dias1Global TB Programme, World Health Organization, Geneva, SwitzerlandRaquel Duarte31General Directorate of Health, Lisbon, PortugalLanfranco Fattorini32Istituto Superiore di Sanita, Rome, ItalyMina Gaga33National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, GreeceHaileyesus Getahun1Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou1Global TB Programme, World Health Organization, Geneva, SwitzerlandLasha Goguadze34International Federation of Red Cross and Red Crescent Societies, Geneva, SwitzerlandMirtha del Granado35WHO Regional Office for the Americas, Washington, DC, USAWalter Haas36Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, GermanyAsko Järvinen37Finnish Lung Health Association, Helsinki, Finland38Helsinki University Central Hospital, Division of Infectious Diseases, Helsinki, FinlandGeun-Yong Kwon39Korea Centers for Disease Control and Prevention (KCDC), Ministry of Health and Welfare, Seoul, Republic of KoreaDavide Mosca40International Organization for Migration, Geneva, SwitzerlandPayam Nahid41University of California, San Francisco, CA, USA42American Thoracic Society (ATS), New York, NY, USANobuyuki Nishikiori43Stop TB and Leprosy Elimination, WHO Regional Office for the Western Pacific, Manila, PhilippinesIsabel Noguer44Instituto de Salud Carlos III, Madrid, SpainJoan O'Donnell45HSE Health Protection Surveillance Centre, Dublin, IrelandAnalita Pace-Asciak46Ministry for Health, Valletta, MaltaMaria G. Pompa47Ministry of Health, Rome, ItalyGilda G. Popescu48Pneumology Institute Marius Nasta, Bucharest, RomaniaCarlos Robalo Cordeiro49Coimbra University Hospital, Coimbra, PortugalKarin Rønning29Norwegian Institute of Public Health, Oslo, NorwayMorten Ruhwald50Statens Serum Institut (SSI), Copenhagen, DenmarkJean-Paul Sculier51Institut Jules Bordet (ULB), Brussels, BelgiumAleksandar Simunović52Croatian National Institute of Public Health, Zagreb, CroatiaAlison Smith-Palmer53Health Protection Scotland, Glasgow, UKGiovanni Sotgiu54Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyGiorgia Sulis1Global TB Programme, World Health Organization, Geneva, SwitzerlandCarlos A. Torres-Duque55Asociacion Latinoamericana de Torax (ALAT) - Fundacion Neumologica Colombiana, Bogota, ColombiaKazunori Umeki56Ministry of Health, Labour and Welfare, Tokyo, JapanMukund Uplekar1Global TB Programme, World Health Organization, Geneva, SwitzerlandCatharina van Weezenbeek4KNCV Tuberculosis Foundation, The Hague, The NetherlandsTuula Vasankari37Finnish Lung Health Association, Helsinki, FinlandRobert J. Vitillo57Caritas Internationalis, Geneva, SwitzerlandConstantia Voniatis58Ministry of Health, Nicosia, CyprusMaryse Wanlin59Fonds des Affections Respiratoires (FARES), Brussels, BelgiumMario C. Raviglione1Global TB Programme, World Health Organization, Geneva, Switzerland
- Towards tuberculosis elimination: an action framework for low-incidence countriesBy Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Lia D'Ambrosio, Gerard de Vries, Roland Diel, Paul Douglas, Dennis Falzon, Marc-Andre Gaudreau, Delia Goletti, Edilberto R. González Ochoa, Philip LoBue, Alberto Matteelli, Howard Njoo, Ivan Solovic, Alistair Story, Tamara Tayeb, Marieke J. van der Werf, Diana Weil, Jean-Pierre Zellweger, Mohamed Abdel Aziz, Mohamed R.M. Al Lawati, Stefano Aliberti, Wouter Arrazola de Oñate, Draurio Barreira, Vineet Bhatia, Francesco Blasi, Amy Bloom, Judith Bruchfeld, Francesco Castelli, Rosella Centis, Daniel Chemtob, Daniela M. Cirillo, Alberto Colorado, Andrei Dadu, Ulf R. Dahle, Laura De Paoli, Hannah M. Dias, Raquel Duarte, Lanfranco Fattorini, Mina Gaga, Haileyesus Getahun, Philippe Glaziou, Lasha Goguadze, Mirtha del Granado, Walter Haas, Asko Järvinen, Geun-Yong Kwon, Davide Mosca, Payam Nahid, Nobuyuki Nishikiori, Isabel Noguer, Joan O'Donnell, Analita Pace-Asciak, Maria G. Pompa, Gilda G. Popescu, Carlos Robalo Cordeiro, Karin Rønning, Morten Ruhwald, Jean-Paul Sculier, Aleksandar Simunović, Alison Smith-Palmer, Giovanni Sotgiu, Giorgia Sulis, Carlos A. Torres-Duque, Kazunori Umeki, Mukund Uplekar, Catharina van Weezenbeek, Tuula Vasankari, Robert J. Vitillo, Constantia Voniatis, Maryse Wanlin and Mario C. RaviglioneArticle | Published in 2015 in European Respiratory JournalKnut Lönnroth1Global TB Programme, World Health Organization, Geneva, Switzerland60Both authors contributed equallyGiovanni Battista Migliori2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy60Both authors contributed equallyIbrahim Abubakar3TB Section, University College London and Public Health England, London, UKLia D'Ambrosio2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyGerard de Vries4KNCV Tuberculosis Foundation, The Hague, The NetherlandsRoland Diel5University Hospital Schleswig Holstein, Institute for Epidemiology, Kiel, GermanyPaul Douglas6Global Health Borders Refugee and Onshore Services, Dept of Immigration and Border Protection, Sydney, AustraliaDennis Falzon1Global TB Programme, World Health Organization, Geneva, SwitzerlandMarc-Andre Gaudreau7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaDelia Goletti8National Institute for Infectious Diseases, Rome, ItalyEdilberto R. González Ochoa9Research and Surveillance Group on TB, Leprosy and ARI, Epidemiology Board, Institute of Tropical Medicine “Pedro Kourí”, Havana, CubaPhilip LoBue10Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USAAlberto Matteelli1Global TB Programme, World Health Organization, Geneva, SwitzerlandHoward Njoo7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaIvan Solovic11TB Dept, National Institute for TB, Respiratory Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ružomberok, SlovakiaAlistair Story12Find and Treat, London, UKTamara Tayeb13National TB Control Programme, Ministry of Health, Riyadh, Saudi ArabiaMarieke J. van der Werf14European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenDiana Weil1Global TB Programme, World Health Organization, Geneva, SwitzerlandJean-Pierre Zellweger15Swiss Lung Association, Bern, SwitzerlandMohamed Abdel Aziz16WHO Regional Office for the Eastern Mediterranean, Cairo, EgyptMohamed R.M. Al Lawati17Ministry of Health, Muscat, OmanStefano Aliberti18Università degli Studi di Milano – Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyWouter Arrazola de Oñate19Belgian Lung and Tuberculosis Association, Brussels, BelgiumDraurio Barreira20Ministry of Health, Brasilia, BrazilVineet Bhatia1Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi21Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyAmy Bloom22US Agency for International Development, Washington, DC, USAJudith Bruchfeld23Unit of Infectious Diseases, Institution of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenFrancesco Castelli24University of Brescia, Brescia, ItalyRosella Centis2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyDaniel Chemtob25Ministry of Health, Jerusalem, IsraelDaniela M. Cirillo26IRCCS San Raffaele Scientific Institute, Milan, ItalyAlberto Colorado27Advocates for Health International, San Diego, CA, USAAndrei Dadu28TB and M/XDR-TB Control Programme, WHO Regional Office for Europe, Copenhagen, DenmarkUlf R. Dahle29Norwegian Institute of Public Health, Oslo, NorwayLaura De Paoli30Médecins sans Frontières, Rome, ItalyHannah M. Dias1Global TB Programme, World Health Organization, Geneva, SwitzerlandRaquel Duarte31General Directorate of Health, Lisbon, PortugalLanfranco Fattorini32Istituto Superiore di Sanita, Rome, ItalyMina Gaga33National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, GreeceHaileyesus Getahun1Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou1Global TB Programme, World Health Organization, Geneva, SwitzerlandLasha Goguadze34International Federation of Red Cross and Red Crescent Societies, Geneva, SwitzerlandMirtha del Granado35WHO Regional Office for the Americas, Washington, DC, USAWalter Haas36Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, GermanyAsko Järvinen37Finnish Lung Health Association, Helsinki, Finland38Helsinki University Central Hospital, Division of Infectious Diseases, Helsinki, FinlandGeun-Yong Kwon39Korea Centers for Disease Control and Prevention (KCDC), Ministry of Health and Welfare, Seoul, Republic of KoreaDavide Mosca40International Organization for Migration, Geneva, SwitzerlandPayam Nahid41University of California, San Francisco, CA, USA42American Thoracic Society (ATS), New York, NY, USANobuyuki Nishikiori43Stop TB and Leprosy Elimination, WHO Regional Office for the Western Pacific, Manila, PhilippinesIsabel Noguer44Instituto de Salud Carlos III, Madrid, SpainJoan O'Donnell45HSE Health Protection Surveillance Centre, Dublin, IrelandAnalita Pace-Asciak46Ministry for Health, Valletta, MaltaMaria G. Pompa47Ministry of Health, Rome, ItalyGilda G. Popescu48Pneumology Institute Marius Nasta, Bucharest, RomaniaCarlos Robalo Cordeiro49Coimbra University Hospital, Coimbra, PortugalKarin Rønning29Norwegian Institute of Public Health, Oslo, NorwayMorten Ruhwald50Statens Serum Institut (SSI), Copenhagen, DenmarkJean-Paul Sculier51Institut Jules Bordet (ULB), Brussels, BelgiumAleksandar Simunović52Croatian National Institute of Public Health, Zagreb, CroatiaAlison Smith-Palmer53Health Protection Scotland, Glasgow, UKGiovanni Sotgiu54Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyGiorgia Sulis1Global TB Programme, World Health Organization, Geneva, SwitzerlandCarlos A. Torres-Duque55Asociacion Latinoamericana de Torax (ALAT) - Fundacion Neumologica Colombiana, Bogota, ColombiaKazunori Umeki56Ministry of Health, Labour and Welfare, Tokyo, JapanMukund Uplekar1Global TB Programme, World Health Organization, Geneva, SwitzerlandCatharina van Weezenbeek4KNCV Tuberculosis Foundation, The Hague, The NetherlandsTuula Vasankari37Finnish Lung Health Association, Helsinki, FinlandRobert J. Vitillo57Caritas Internationalis, Geneva, SwitzerlandConstantia Voniatis58Ministry of Health, Nicosia, CyprusMaryse Wanlin59Fonds des Affections Respiratoires (FARES), Brussels, BelgiumMario C. Raviglione1Global TB Programme, World Health Organization, Geneva, Switzerland
- Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern ItalyBy Laura Gillini, Rosella Centis, Lia D'Ambrosio, Alberto Fedele, Valerio Aprile, Giancarlo Pasanisi, Leonardo Donateo, Danila Costa, Giovanni Battista Migliori and Paolo TundoArticle | Published in 2015 in European Respiratory JournalLaura Gillini1World Health Organization, Division of Pacific Technical Support, Suva, FijiRosella Centis2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'Ambrosio2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyAlberto Fedele3Prevention Dept, Hygiene and Public Health Service, Local Health Agency, Lecce, ItalyValerio Aprile3Prevention Dept, Hygiene and Public Health Service, Local Health Agency, Lecce, ItalyGiancarlo Pasanisi4Laboratory Medicine Dept, “Card. G. Panico” Hospital, Tricase, ItalyLeonardo Donateo5Executive Pneumology and Tuberculosis Control Services, Lecce Health Directorate, Lecce, ItalyDanila Costa6Microbiology and Virology Unit, Mycobacteria laboratory, University Hospital, Policlinico, Bari, ItalyGiovanni Battista Migliori2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyPaolo Tundo7Infectious Diseases Dept, “S. Caterina Novella” Hospital, Galatina, Italy
- Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern ItalyBy Laura Gillini, Rosella Centis, Lia D'Ambrosio, Alberto Fedele, Valerio Aprile, Giancarlo Pasanisi, Leonardo Donateo, Danila Costa, Giovanni Battista Migliori and Paolo TundoLaura Gillini1World Health Organization, Division of Pacific Technical Support, Suva, FijiRosella Centis2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'Ambrosio2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyAlberto Fedele3Prevention Dept, Hygiene and Public Health Service, Local Health Agency, Lecce, ItalyValerio Aprile3Prevention Dept, Hygiene and Public Health Service, Local Health Agency, Lecce, ItalyGiancarlo Pasanisi4Laboratory Medicine Dept, “Card. G. Panico” Hospital, Tricase, ItalyLeonardo Donateo5Executive Pneumology and Tuberculosis Control Services, Lecce Health Directorate, Lecce, ItalyDanila Costa6Microbiology and Virology Unit, Mycobacteria laboratory, University Hospital, Policlinico, Bari, ItalyGiovanni Battista Migliori2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyPaolo Tundo7Infectious Diseases Dept, “S. Caterina Novella” Hospital, Galatina, Italy
- Tuberculosis elimination, patients' lives and rational use of new drugs: revisitedBy Simon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, Pietro Viggiani, Rosella Centis and Giovanni Battista MiglioriArticle | Published in 2015 in European Respiratory JournalSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK5These authors contributed equallyLia D'Ambrosio2Public Health Consulting Group, Lugano, Switzerland3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy5These authors contributed equallySaverio De Lorenzo4Eugenio Morelli MDR-TB Reference Hospital, AOVV, Sondalo, Italy5These authors contributed equallyPietro Viggiani4Eugenio Morelli MDR-TB Reference Hospital, AOVV, Sondalo, ItalyRosella Centis3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalyGiovanni Battista Migliori3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experienceBy Simon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, Pietro Viggiani, Rosella Centis, Giovanni Sotgiu, Jan Wilem C. Alffenaar and Giovanni Battista MiglioriArticle | Published in 2015 in European Respiratory JournalSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK7These authors contributed equallyLia D'Ambrosio2Public Health Consulting Group, Lugano, Switzerland3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy7These authors contributed equallySaverio De Lorenzo4Eugenio Morelli MDR-TB Reference Hospital, AOVV, Sondalo, Italy7These authors contributed equallyPietro Viggiani4Eugenio Morelli MDR-TB Reference Hospital, AOVV, Sondalo, ItalyRosella Centis3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalyGiovanni Sotgiu5Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyJan Wilem C. Alffenaar6University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The NetherlandsGiovanni Battista Migliori3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experienceBy Simon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, Pietro Viggiani, Rosella Centis, Giovanni Sotgiu, Jan Wilem C. Alffenaar and Giovanni Battista MiglioriSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK7These authors contributed equallyLia D'Ambrosio2Public Health Consulting Group, Lugano, Switzerland3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy7These authors contributed equallySaverio De Lorenzo4Eugenio Morelli MDR-TB Reference Hospital, AOVV, Sondalo, Italy7These authors contributed equallyPietro Viggiani4Eugenio Morelli MDR-TB Reference Hospital, AOVV, Sondalo, ItalyRosella Centis3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalyGiovanni Sotgiu5Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyJan Wilem C. Alffenaar6University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The NetherlandsGiovanni Battista Migliori3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidenceBy Emanuele Pontali, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis and Giovanni Battista MiglioriEmanuele Pontali1Dept of Infectious Diseases, Galliera Hospital, Genova, Italy5Both authors contributed equallyGiovanni Sotgiu2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences - University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy5Both authors contributed equallyLia D'Ambrosio3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy4Public Health Consulting Group, Lugano, SwitzerlandRosella Centis3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyGiovanni Battista Migliori3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Tuberculosis elimination, patients' lives and rational use of new drugs: revisitedBy Simon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, Pietro Viggiani, Rosella Centis and Giovanni Battista MiglioriSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK5These authors contributed equallyLia D'Ambrosio2Public Health Consulting Group, Lugano, Switzerland3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy5These authors contributed equallySaverio De Lorenzo4Eugenio Morelli MDR-TB Reference Hospital, AOVV, Sondalo, Italy5These authors contributed equallyPietro Viggiani4Eugenio Morelli MDR-TB Reference Hospital, AOVV, Sondalo, ItalyRosella Centis3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalyGiovanni Battista Migliori3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migrationBy Alberto Matteelli, Knut Lönnroth, Davide Mosca, Haileyesus Getahun, Rosella Centis, Lia D'Ambrosio, Ernesto Jaramillo, Giovanni Battista Migliori and Mario C. RaviglioneAlberto Matteelli1Clinic of Infectious and Tropical Diseases, University of Brescia, Brescia, ItalyKnut Lönnroth2The Global TB Programme, World Health Organization, Geneva, Switzerland3Dept of Public Health Sciences, Karolinska Institutet, Stockholm, SwedenDavide Mosca4Migration Health Dept, International Organization of Migration, Geneva, SwitzerlandHaileyesus Getahun2The Global TB Programme, World Health Organization, Geneva, SwitzerlandRosella Centis5WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, ItalyLia D'Ambrosio5WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, Italy6Public Health Consulting Group, Lugano, SwitzerlandErnesto Jaramillo2The Global TB Programme, World Health Organization, Geneva, SwitzerlandGiovanni Battista Migliori5WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, ItalyMario C. Raviglione2The Global TB Programme, World Health Organization, Geneva, Switzerland
- Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, Lia D'Ambrosio, Valentina Alarcon Guizado, Jan Willem Alffenaar, Marcos Abdo Arbex, Jose A. Caminero, Rosella Centis, Saverio De Lorenzo, Mina Gaga, Gina Gualano, Aurora Jazmín Roby Arias, Anna Scardigli, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Onno W. Akkerman, Edith Alarcon Arrascue, Alena Aleska, Vera Avchinko, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriArticle | Published in 2016 in European Respiratory JournalSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workMarie-Christine Payen2Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium30These authors contributed equally to this workGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy5Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workValentina Alarcon Guizado6National Tuberculosis Control Programme, Ministry of Health, Lima, PeruJan Willem Alffenaar7Dept of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsMarcos Abdo Arbex8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilJose A. Caminero10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, Spain11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalySaverio De Lorenzo12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyMina Gaga13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAurora Jazmín Roby Arias15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceAlena Skrahina16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic17National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, SlovakiaGiorgia Sulis18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini19Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyOnno W. Akkerman20Dept of Pulmonary Diseases and Tuberculosis, TB Center Beatrixoord, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsEdith Alarcon Arrascue11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France21International Union Against Tuberculosis and Lung Disease (The Union), Lima, PeruAlena Aleska22Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Avchinko16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries23KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst24Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, Lia D'Ambrosio, Valentina Alarcon Guizado, Jan Willem Alffenaar, Marcos Abdo Arbex, Jose A. Caminero, Rosella Centis, Saverio De Lorenzo, Mina Gaga, Gina Gualano, Aurora Jazmín Roby Arias, Anna Scardigli, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Onno W. Akkerman, Edith Alarcon Arrascue, Alena Aleska, Vera Avchinko, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workMarie-Christine Payen2Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium30These authors contributed equally to this workGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy5Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workValentina Alarcon Guizado6National Tuberculosis Control Programme, Ministry of Health, Lima, PeruJan Willem Alffenaar7Dept of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsMarcos Abdo Arbex8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilJose A. Caminero10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, Spain11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalySaverio De Lorenzo12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyMina Gaga13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAurora Jazmín Roby Arias15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceAlena Skrahina16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic17National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, SlovakiaGiorgia Sulis18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini19Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyOnno W. Akkerman20Dept of Pulmonary Diseases and Tuberculosis, TB Center Beatrixoord, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsEdith Alarcon Arrascue11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France21International Union Against Tuberculosis and Lung Disease (The Union), Lima, PeruAlena Aleska22Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Avchinko16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries23KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst24Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease: call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugeesBy Masoud Dara, Ivan Solovic, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Delia Goletti, Raquel Duarte, Stefano Aliberti, Fernando Maria de Benedictis, Graham Bothamley, Tom Schaberg, Ibrahim Abubakar, Brian Ward, Vitor Teixeira, Christina Gratziou and Giovanni Battista MiglioriArticle | Published in 2016 in European Respiratory JournalMasoud Dara1World Health Organization Office at the European Union, Brussels, BelgiumIvan Solovic2National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, SlovakiaGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, Italy5Public Health Consulting Group, Lugano, SwitzerlandRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, ItalyDelia Goletti6National Institute for Infectious Diseases, Rome, ItalyRaquel Duarte7EPI Unit, Institute of Public Health, University of Porto, Porto, PortugalStefano Aliberti8School of Medicine and Surgery, University of Milan-Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyFernando Maria de Benedictis9Paediatric Italian Society, Section Marche, Ancona, ItalyGraham Bothamley10Dept of Respiratory Medicine, Homerton University Hospital NHS Foundation Trust, London, UKTom Schaberg11Dept of Pneumology, Deaconess Hospital Rotenburg, Rotenburg (Wümme), GermanyIbrahim Abubakar12Centre for Infectious Disease Epidemiology, UCL and Tuberculosis Section, Public Health England, London, UKBrian Ward13European Respiratory Society, EU Affairs Dept, Brussels, BelgiumVitor Teixeira13European Respiratory Society, EU Affairs Dept, Brussels, BelgiumChristina Gratziou14University Respiratory Medicine Unit, Evgenidio Hospital, Athens, GreeceGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, Italy
- Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung DiseaseBy Masoud Dara, Ivan Solovic, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Delia Goletti, Raquel Duarte, Stefano Aliberti, Fernando Maria de Benedictis, Graham Bothamley, Tom Schaberg, Ibrahim Abubakar, Brian Ward, Vitor Teixeira, Christina Gratziou and Giovanni Battista MiglioriMasoud Dara1World Health Organization Office at the European Union, Brussels, BelgiumIvan Solovic2National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, SlovakiaGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, Italy5Public Health Consulting Group, Lugano, SwitzerlandRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, ItalyDelia Goletti6National Institute for Infectious Diseases, Rome, ItalyRaquel Duarte7EPI Unit, Institute of Public Health, University of Porto, Porto, PortugalStefano Aliberti8School of Medicine and Surgery, University of Milan-Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyFernando Maria de Benedictis9Paediatric Italian Society, Section Marche, Ancona, ItalyGraham Bothamley10Dept of Respiratory Medicine, Homerton University Hospital NHS Foundation Trust, London, UKTom Schaberg11Dept of Pneumology, Deaconess Hospital Rotenburg, Rotenburg (Wümme), GermanyIbrahim Abubakar12Centre for Infectious Disease Epidemiology, UCL and Tuberculosis Section, Public Health England, London, UKBrian Ward13European Respiratory Society, EU Affairs Dept, Brussels, BelgiumVitor Teixeira13European Respiratory Society, EU Affairs Dept, Brussels, BelgiumChristina Gratziou14University Respiratory Medicine Unit, Evgenidio Hospital, Athens, GreeceGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, Italy
- Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Marcos Abdo Arbex, Edith Alarcon Arrascue, Jan Willem Alffenaar, Jose A. Caminero, Mina Gaga, Gina Gualano, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Valentina Alarcon Guizado, Saverio De Lorenzo, Aurora Jazmín Roby Arias, Anna Scardigli, Onno W. Akkerman, Alena Aleksa, Janina Artsukevich, Vera Auchynka, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Marie-Christine Payen, Andrea Piana, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriArticle | Published in 2016 in European Respiratory JournalSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workGiovanni Sotgiu2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy4Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workRosella Centis3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy30These authors contributed equally to this workMarcos Abdo Arbex5University Center of Araraquara, Sao Paulo, Brazil6Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilEdith Alarcon Arrascue7International Union against Tuberculosis and Lung Disease (The Union), Lima, Peru8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, FranceJan Willem Alffenaar9University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The NetherlandsJose A. Caminero8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, SpainMina Gaga11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano12Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAlena Skrahina13Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic14National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, SlovakiaGiorgia Sulis15University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini16Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyValentina Alarcon Guizado17National Tuberculosis Control Programme, Ministry of Health, Lima, PeruSaverio De Lorenzo18AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyAurora Jazmín Roby Arias19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, FranceOnno W. Akkerman20University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis; TB Center Beatrixoord, Groningen, The NetherlandsAlena Aleksa21Educational Institution “Grodno State Medical University”, Grodno, BelarusJanina Artsukevich21Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Auchynka13Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini5University Center of Araraquara, Sao Paulo, Brazil6Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries22KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst23Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli15University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri12Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceMarie-Christine Payen24Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, BelgiumAndrea Piana2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani18AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- TuberculosisEdited by Giovanni Battista Migliori, Graham Bothamley, Raquel Duarte and Adrian RendonBook | Published in 2018DOI: 10.1183/2312508X.erm8218ISBN (electronic): 978-1-84984-100-9Giovanni Battista MiglioriGraham BothamleyRaquel Duarte
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.